May 19, 2020 / 8:27 PM / 3 months ago

BRIEF-Ascendis Reports Q1 Loss Per Share Of EUR 1.32

May 19 (Reuters) - Ascendis Pharma A/S:

* Q1 REVENUE EUR 2.2 MILLION VERSUS EUR 5.4 MILLION

* ASCENDIS PHARMA - ON TRACK FOR FILING U.S. BLA FOR TRANSCON HGH IN Q2, ADVANCING MARKETING AUTHORISATION APPLICATION IN EUROPE TO Q3

* ENDED Q1 2020 WITH CASH AND CASH EQUIVALENTS OF EUR 534.4 MILLION

* Q1 EARNINGS PER SHARE VIEW EUR -1.35, REVENUE VIEW EUR 1.9 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below